Opinion: Kidney Transplantation
- 作者Sarbjit V. Jassal
- 卷第22卷
- 期第1期
- 印刷ISSN0894-0959
- 电子ISSN1525-139X
- 文件大小134.93KB
- 发表时间2009
- DOI10.1111/j.1525-139x.2008.00511.x
- 页码29-34
What are the Considerations in Balancing Benefits and Risks in Iron Treatment?Fishbane, Steven; Fishbane, Steven · Seminars in Dialysis · 2016
How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?Shah, Hitesh H.; Fishbane, Steven N.; Fishbane, Steven N. · Seminars in Dialysis · 2013
How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?Shirazian, Shayan; Grant, Candace; Miller, Ilene; Fishbane, Steven; Fishbane, Steven N. · Seminars in Dialysis · 2013
Safety of Intravenous Iron During InfectionsSteven Fishbane · 2001
Hepatic iron in hemodialysis patientsFISHBANE, STEVEN; MIYAWAKI, NOBUYUKI; MASANI, NAVEED · Kidney International · 2004
Rechallenging Patients Allergic to Iron DextranSteven Fishbane · 1998
Pharmacokinetics and utilization of iron sucroseSteven Fishbane · 2003
Safety issues with iron sucroseSteven Fishbane · 2003